Description
Ceritinib 150 mg – Targeted Therapy for ALK-Positive Non-Small Cell Lung Cancer (NSCLC)
Ceritinib 150 mg is a prescription-only oral chemotherapy medication used in the treatment of ALK-positive metastatic non-small cell lung cancer (NSCLC). It belongs to a class of drugs known as ALK inhibitors, which target and block the abnormal ALK protein that promotes cancer cell growth. Ceritinib is particularly recommended for patients who have not responded to or cannot tolerate other ALK inhibitor therapies such as Crizotinib.
What is Ceritinib 150 mg Used For?
This medicine is used for the treatment of ALK-positive NSCLC in adults. ALK (anaplastic lymphoma kinase) gene mutations are found in a small subset of lung cancer patients. Ceritinib helps slow the progression of cancer by inhibiting the ALK protein, which contributes to uncontrolled cell growth.
Key Indications:
- First-line treatment of ALK-positive metastatic NSCLC
- Patients with disease progression after prior ALK therapy
- Patients who are intolerant to previous ALK inhibitor drugs
How Ceritinib 150 mg Works
Ceritinib selectively targets and inhibits the ALK tyrosine kinase enzyme, which is responsible for the growth and spread of ALK-positive cancer cells. By blocking this pathway, Ceritinib slows down tumor growth and helps shrink existing tumors. It is an effective option for patients with ALK gene rearrangements and is known for its ability to cross the blood-brain barrier, offering benefit in brain metastases as well.
Dosage and Administration
- Usual Dose: 750 mg once daily (taken as five 150 mg capsules)
- Administration: Take with food to improve absorption and reduce gastrointestinal side effects
- Swallow capsules whole; do not crush or chew
- Continue treatment as long as it is tolerated or until disease progression
Always follow the dosage and schedule prescribed by your oncologist. Dose adjustments may be required based on side effects and lab results.
Side Effects of Ceritinib 150 mg
Common side effects include:
- Nausea, vomiting, or diarrhea
- Fatigue
- Abdominal pain
- Loss of appetite
- Elevated liver enzymes
- High blood sugar (hyperglycemia)
Serious side effects may include lung inflammation, liver damage, QT prolongation, or pancreatitis. Routine blood tests and heart monitoring are necessary during treatment.
Precautions and Warnings
- Not recommended during pregnancy or breastfeeding
- Monitor liver function, blood glucose, and heart rhythm regularly
- Inform your doctor of all medications, especially strong CYP3A4 inhibitors or inducers
- Use effective contraception during and for several weeks after treatment
Why Buy Ceritinib 150 mg from ReliableVita?
- 100% authentic anti-cancer medications from trusted manufacturers
- Strict quality control and safe handling of oncology products
- Secure checkout and discreet global shipping
- Excellent customer support and wholesale pricing options
Related Oncology Medications:
- Afatinib 40 mg – EGFR inhibitor for NSCLC
Frequently Asked Questions (FAQs)
1. What is Ceritinib 150 mg used for?
Ceritinib 150 mg is used for the treatment of ALK-positive non-small cell lung cancer, particularly in patients who are intolerant to or have progressed on previous ALK inhibitor therapy.
2. How should I take Ceritinib?
The usual dose is 750 mg once daily, taken with food. Do not chew or crush the capsules. Follow your doctor’s instructions exactly.
3. What are the side effects of Ceritinib?
Common side effects include nausea, diarrhea, fatigue, and elevated liver enzymes. Serious effects may include liver toxicity or heart rhythm disturbances.
4. Can Ceritinib be used during pregnancy?
No, Ceritinib is not safe during pregnancy or breastfeeding due to potential harm to the fetus.
5. Where can I buy Ceritinib 150 mg online?
You can buy Ceritinib 150 mg online from ReliableVita.com, which offers genuine cancer medications with secure global delivery.
